Sun Pharmaceutical Industries, Inc. of Cranbury, N.J., is recalling 34,000 bottles of Diltiazem Hydrochloride extended-release capsules. The generic drug is used to treat high blood pressure and chest pain.
The company said it is recalling the drug because certain lots of the prescription drug failed impurity tests at a U.S. Food and Drug Administration (FDA) laboratory.
The recall includes:
Lot # HAC3120A: 6912 Bottles
Lot # HAC3121A: 6792 Bottles
Lot # HAC4460A: 6816 Bottles
Lot # HAD0365A: 6744 Bottles
Lot # HAD1452A: 6840 Bottles
The drugs were distributed throughout the U.S. and have expiration dates ranging from April 2023 to February 2024.
Sun Pharma first announced the recall last month but this week upgraded it to Class 2, meaning the product “may cause” temporary health issues that, in rare cases, could be serious.